|
MechanismZFP91 gene modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismATXN2 gene modulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismCACNA1A gene modulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Smart Therapeutics, Inc.
0 Patents (Medical) associated with Smart Therapeutics, Inc.
100 Deals associated with Smart Therapeutics, Inc.
100 Translational Medicine associated with Smart Therapeutics, Inc.